Skip to content
GLP-1 Savers
Cheapest GLP-1
Provider review

Goldspan Health review

Value Score71/100

A single-plan desk with no commitment tiers and no introductory month, selling compounded semaglutide at $229 and tirzepatide at $299 — priced "/month" in the hero and billed every 28 days on the plan card, which is thirteen charges a year.

By Grant Ashford, Founder & Pricing Editor

We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. It never changes the Value Score.

Advertised price

From $229

$229 every 28 days, month-to-month (thirteen charges a year, not twelve)

Visit Goldspan Health Compare alternatives
Pricing to watch. One plan, one price, no commitment tiers and no introductory month — which removes most of the traps this site looks for. What replaces them is a calendar problem. The hero says "/month"; the plan card says billed every 28 days; the order timeline says the order renews every four weeks. Twenty-eight-day billing comes round thirteen times a year, so $229 a month is $2,977 rather than $2,748, and $299 is $3,887 rather than $3,588 — a difference of about $230 and $300 a year that the word "month" hides. The low-dose lines are the cheap end here: $149 for a daily sublingual semaglutide and $199 for the tirzepatide version, on the same twenty-eight-day cycle.

How much does Goldspan Health cost?

The price Goldspan Health publishes is $229 every 28 days, month-to-month (thirteen charges a year, not twelve). Tirzepatide is listed at $299 every 28 days, month-to-month (thirteen charges a year, not twelve). We flag this one to watch: confirm the ongoing rate with Goldspan Health before you count on it.

Semaglutide
$229 every 28 days, month-to-month (thirteen charges a year, not twelve)
Tirzepatide
$299 every 28 days, month-to-month (thirteen charges a year, not twelve)
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

The Value Score card

Goldspan Health scored on our six published factors. See the methodology.

Lowest Real Price71/100
No Teaser-Rate Bait64/100
Both Molecules98/100
Nationwide Availability72/100
Easy Cancellation58/100
Reputation66/100

What's good

  • One plan and one price per product: no three-, six- or twelve-month ladder, no introductory rate, and nothing to lock into — the commitment trap simply is not present
  • The catalog is unusually broad and openly priced: injectable and daily sublingual, full dose and low dose, semaglutide and tirzepatide, at $229, $299, $199, $299, $149 and $199 respectively
  • The pharmacy class is stated plainly — all therapies dispensed by a pharmacy licensed under section 503A or 503B — which is more than most desks put in writing, even though no pharmacy is named
  • Three clinicians are named with their roles and specialties on the storefront that fulfills the orders, and a phone number is published there
  • The order timeline tells you when the renewal lands rather than leaving the cadence to be discovered on a card statement, and pausing, delaying or canceling is offered through the portal

Read the fine print

  • A month here is twenty-eight days. The hero says "/month", the plan card says billed every 28 days and the timeline says every four weeks — thirteen charges a year, so the real annual cost is about $230 higher on semaglutide and $300 higher on tirzepatide than the monthly framing implies
  • The cancellation promise and the refund policy contradict each other: pause, delay or cancel at any time on one page, all sales final on another, and "once you place an order it cannot be canceled" in the storefront's own terms
  • The brand publishes no legal entity, no address and no governing law of its own — the only company details on the transaction belong to the storefront that fulfills it
  • No pharmacy is named, and the clinicians named belong to that storefront while the same storefront states it is not a medical practice
  • All 50 states is claimed on the homepage while the terms say some therapies are unavailable in certain states, and no list is published either way
  • The full-dose sublingual products at $199 and $299 are not linked from the weight-loss page, so the cheapest oral route is reachable only by finding the catalog
  • One product page's inclusion list names the wrong molecule — a tirzepatide page describing compounded sublingual semaglutide — which is the kind of copy error that matters on a prescription product

The bottom line

Best for: Shoppers who want a flat single-tier price with no plan ladder to decode, and who will do the thirteen-charge arithmetic before comparing it with a calendar-month rate.

For comparison, see CoreAge Rx, a featured partner (Value Score 81/100).

Visit Goldspan Health

Programs to compare

Compare with other deals

The programs scoring closest to Goldspan Health, out of 428 others we track.

Shopping Goldspan Health against a specific rival? We put it head to head with our featured partner on CoreAge Rx vs Goldspan Health, and every program that undercuts or outscores it — starting with ShapeIn Rx, the closest match on score — is ranked on the Goldspan Health alternatives ranking.

More programs we track (24)

395 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page come from Goldspan Health's own website; the Value Score is our editorial judgment per the methodology."% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on Goldspan Health's site. Not medical advice; see our disclosure.

See the cheapest programs →

← Back to all deals